Navigation Links
Optimer Pharmaceuticals Reports First Quarter 2011 Financial Results
Date:5/5/2011

SAN DIEGO, May 5, 2011 /PRNewswire/ -- Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) today announced its financial results for the quarter ended March 31, 2011.

Optimer reported net income for the first quarter of 2011 of $45.1 million, or $1.06 and $1.04 per basic and diluted share, respectively, as compared to a net loss for the first quarter of 2010 of $13.5 million, or ($0.39) per share on both a basic and diluted basis.  The increase in net income was primarily due to licensing revenue from a $69.2 million upfront payment received from Astellas Pharma in connection with the DIFICID™ collaboration and license agreement. The increase was partially offset by a $10.4 million increase in operating expenses, including $4.3 million in licensing costs due to a royalty payment to Par Pharmaceutical associated with the Astellas upfront payment.

In addition, marketing expenses for the first quarter of 2011 increased $3.2 million compared to the prior year period due to market research and pre-commercialization efforts related to the DIFICID program.  General and administrative expenses increased $5.9 million compared to the first quarter of 2010 due to increases in consulting expenses and advisory fees related to DIFICID collaborations, increases in compensation expense, including a $1.0 million increase in stock compensation expense, and increased headcount, including the establishment of a market access team.  Research and development expenses decreased $2.9 million compared to the first quarter of 2010 due to a $5.0 million milestone payment in the prior year due to Par for the successful completion of the second DIFICID Phase 3 trial offset by an increase in medical affairs and publication expenses.

As of March 31, 2011, Optimer held cash, cash equivalents and short-term investments of $180.1 million.

"Optimer was extremely productive i
'/>"/>

SOURCE Optimer Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Optimer Pharmaceuticals Expands Senior Management Team
2. Optimer Pharmaceuticals to Present at May 2011 Investor Conferences
3. Optimer Pharmaceuticals and Cubist Pharmaceuticals Announce Collaboration to Co-Promote DIFICID™ (Fidaxomicin) for Clostridium difficile Infection in the United States
4. Optimer Announces that the U.S. Food and Drug Administrations Anti-Infective Drugs Advisory Committee Voted Unanimously to Recommend Approval of Novel Antibiotic Dificid™ for Treatment of Patients with Clostridium difficile infection (CDI)
5. Trading Halted Today in Optimer Pharmaceuticals Stock
6. Optimer Pharmaceuticals Announces Presentation at SHEA of Data Highlighting the Burden of Clostridium difficile Infection (CDI) in Hospital Patients
7. Optimer Pharmaceuticals Announces Presentation at Upcoming SHEA Annual Meeting Regarding Hospital CDI Patients at Risk of Recurrence and Mortality
8. Optimer Pharmaceuticals Announces Issuance of Key Patent Covering Fidaxomicin Methods of Use as a Treatment of Clostridium difficile infection
9. Optimer Pharmaceuticals Reports Fourth Quarter and Full Year 2010 Financial Results
10. Optimer Pharmaceuticals to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2010 Financial Results
11. Optimer Pharmaceuticals to Present at March 2011 Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... Texas , Sept. 4, 2015  Luminex Corporation ... present at the Morgan Stanley Global Healthcare Conference to ... Grand Hyatt Hotel in New York City ... at 11:40 a.m. Eastern time on Friday, September 18, ... accessed at Luminex Corporation,s website at http://www.luminexcorp.com . ...
(Date:9/4/2015)... 4, 2015 According to a ... Plateletpheresis, Erythrocytapheresis, Leukapheresis, and Photopheresis) by Procedure (Therapeutic Apheresis, ... - Global Forecast to 2020", published by MarketsandMarkets, the ... Billion by 2020, growing at a CAGR of 11.2% ... Browse 139 Tables and 45 F ...
(Date:9/4/2015)... Oramed Pharmaceuticals Inc. (NASDAQ: ... focused on the development of oral drug delivery systems, ... upcoming Rodman & Renshaw 17 th Annual Global ... New York City .  Dr. Michael ... overview on September 9, 2015. Presentation ...
Breaking Medicine Technology:Luminex Corporation To Present At The Morgan Stanley Global Healthcare Conference 2Apheresis Market Worth 2.5 Billion USD by 2020 2Apheresis Market Worth 2.5 Billion USD by 2020 3Apheresis Market Worth 2.5 Billion USD by 2020 4Apheresis Market Worth 2.5 Billion USD by 2020 5Oramed to Present at the Rodman & Renshaw Global Investment Conference 2Oramed to Present at the Rodman & Renshaw Global Investment Conference 3
... 2011 Par Pharmaceutical Companies, Inc. (NYSE: PRX ... EST on Friday, January 6, 2012 at the Millennium Hotel, ... Executive Officer, Patrick G. LePore, and other members of the ... growth strategy, current products and pipelines, and business outlook to ...
... Calif., Dec. 5, 2011  Beyond Lucid Technologies, Inc., ... disaster management, and First Response industries, today announced ... the mHealth Summit, and the publication of a ... connect ambulances with hospitals via telemedicine. ...
Cached Medicine Technology:Beyond Lucid Technologies Advances Telemedicine for EMS Providers 2Beyond Lucid Technologies Advances Telemedicine for EMS Providers 3
(Date:9/4/2015)... ... September 04, 2015 , ... Mile High Connects today releases ... a lack of funding for sidewalks, bike paths, and other vital supports severely limit ... Denver region spends billions of dollars to expand public transit, there’s very little support ...
(Date:9/4/2015)... ... ... After wearing the same uniforms for six seasons, the Sprayberry High School girls ... the team, the Jones Agency, a locally owned insurance firm that serves communities in ... uniforms. , As is so often the case with high school and many school-related ...
(Date:9/4/2015)... San Francisco, CA (PRWEB) , ... September 04, ... ... Ben Amini, announces that CEREC technology is now available at CitiDent. CEREC is ... milling machinery. In addition to saving time for patients by eliminating the need ...
(Date:9/4/2015)... ... September 04, 2015 , ... The USC Eye Institute is proud to announce ... Doximity. Faculty, residents and staff are honored to have contributed to the success ... our ophthalmology residency program. Our faculty places a high priority on our educational programs ...
(Date:9/4/2015)... ... September 04, 2015 , ... Steven Winter Associates, Inc., (SWA) ... been selected for the Residential Award of Merit by the Connecticut Green Building ... from a highly competitive field of submissions, the net-zero energy residence will be ...
Breaking Medicine News(10 mins):Health News:Missed Connections in Metro Denver Transit 2Health News:The Jones Agency Serves Up a Charity Drive to Fund New Uniforms for the Sprayberry High School Girls Volleyball Team 2Health News:The Jones Agency Serves Up a Charity Drive to Fund New Uniforms for the Sprayberry High School Girls Volleyball Team 3Health News:San Francisco Dentist, Dr. Ben Amini, is Now Offering CEREC Technology at CitiDent 2Health News:USC Ophthalmology Residency Program Ranked in Top 10 by Doximity 2Health News:USC Ophthalmology Residency Program Ranked in Top 10 by Doximity 3Health News:South Glastonbury Home Selected for Award by Connecticut Green Building Council 2
... (Nasdaq: ERES ), a leading provider of ... the biopharmaceutical, medical device, and related industries, is to ... state-of-the-art headquarters and logistics operations in Philadelphia. This strategic ... and support its growing customer base and deliver enhanced ...
... Predecessor Heinrich Kolem will lead the global angiography, fluoroscopy and X-ray ... Reitermann has been appointed the new CEO of Siemens Healthcare,s ... In his new position, Reitermann will lead the marketing, sales ... , including the medical imaging, therapy and health care information ...
... conversations speed language development, study finds, , MONDAY, June 29 ... language and speech skills, UCLA researchers say, listening to what ... to them. , The effect of a conversation between ... great as the effect of adult speech input alone, the ...
... Va., June 29 Perot Systems Corporation (NYSE: ... Government Services Business Unit, won the re-compete for the ... Prevention (CDC) valued at over $119 million. Perot Systems ... the CDC,s Information Technology Services Office nationally and internationally. ...
... ... to Gain Greater Risk Visibility, Simplify and Centralize Compliance Efforts while Trimming Costs ... Scottsdale, Ariz. (PRWEB) ... security , has partnered with Network Frontiers , a leader in IT compliance, ...
... Its Patient Assistance Program to 400 Percent of Federal Poverty; ... Qualify for This Program , , GAITHERSBURG, Md., June ... Assistance Program for Synagis(R) (palivizumab) designed to provide the antibody ... and whose family household income falls within a certain range ...
Cached Medicine News:Health News:ERT Relocates Customer Care Team to Provide Stronger Client Support 2Health News:ERT Relocates Customer Care Team to Provide Stronger Client Support 3Health News:Michael Reitermann to Head Siemens Healthcare U.S. Organization 2Health News:Talk With Kids, Not At Them 2Health News:Talk With Kids, Not At Them 3Health News:Perot Systems Wins Over $119 Million CDC Contract 2Health News:Lumension Integrates With Network Frontiers' Unified Compliance Framework To Simplify Compliance Challenges, Reduce Costs, And Harmonize Controls 2Health News:Lumension Integrates With Network Frontiers' Unified Compliance Framework To Simplify Compliance Challenges, Reduce Costs, And Harmonize Controls 3Health News:Lumension Integrates With Network Frontiers' Unified Compliance Framework To Simplify Compliance Challenges, Reduce Costs, And Harmonize Controls 4Health News:Lumension Integrates With Network Frontiers' Unified Compliance Framework To Simplify Compliance Challenges, Reduce Costs, And Harmonize Controls 5Health News:Lumension Integrates With Network Frontiers' Unified Compliance Framework To Simplify Compliance Challenges, Reduce Costs, And Harmonize Controls 6Health News:MedImmune Expands Access for Eligible Premature Infants to Receive Synagis(R) at No Cost 2Health News:MedImmune Expands Access for Eligible Premature Infants to Receive Synagis(R) at No Cost 3
Adjustable piston accommodates 7-9mm trephine blade. Complete punch includes base plate, piston carrier, piston for 7 - 9mm trephine blades and 18mm diameter Teflon block. Designed for accurate donor...
... Centuries of German Craftsmanship ... surgical instrumentation in the ... them available to you! ... coveted Meisterbrief certificate, which ...
... Centuries of German Craftsmanship ... surgical instrumentation in the ... them available to you! ... coveted Meisterbrief certificate, which ...
... German Craftsmanship have produced ... in the world. Ocutek ... to you! Only holders ... certificate, which requires and ...
Medicine Products: